Form 4 · Filed Jun 3, 2026, 11:15 PM UTC
CORT/CORCEPT THERAPEUTICS INC
Robb Gary Charles — Chief Business Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | F | other | 358 | $70 | $25,218 | 25,681 |
| Jun 1, 2026 | A | other | 776 | $70 | $54,661 | 25,263 |
| Jun 1, 2026 | A | other | 776 | $0 | $0 | 26,039 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-256002